RESUMEN
Culture media modifications, including the addition of various factors, are important for the in vitro production of oocytes and embryos. In this study, we investigated the effects of lysophosphatidic acid (LPA) on porcine embryo development. Porcine parthenogenetic embryos were cultured with 0, 0.1, 1, and 10 µM LPA for 7 days, or cultured in basic medium until Day 4 and then treated with LPA from Days 4 to 7. No difference in the in vitro development of embryos cultured with LPA for 7 days was observed. Conversely, rates of blastocyst and over-expanded blastocyst formation were higher in the 0.1 and 1 µM LPA-treated versus the other groups of embryos treated from Days 4 to 7. Moreover, formation of early blastocysts occurred earlier and embryo size was larger in LPA-treated compared to control embryos. Expression of Connexin 43 and gap junction and cell adhesion-related genes (GJC1 and CDH1, respectively) was also higher in LPA-treated compared to control embryos. Despite no difference in the blastocyst total cell number between groups, the apoptotic index was lower in the LPA-treated group than in the control group; indeed, BCL2L1 (B-cell lymphoma 2-like protein 1) expression increased while BAK (Bcl-2 homologous antagonist killer) decreased in the LPA-treated group. Thus, addition of LPA to the medium from Days 4 to 7 of culture improves blastocyst formation and aids the development of preimplantation embryos.
Asunto(s)
Blastocisto/citología , Embrión de Mamíferos/embriología , Desarrollo Embrionario/efectos de los fármacos , Lisofosfolípidos/farmacología , Animales , Proteínas Cdh1/biosíntesis , Conexina 43/biosíntesis , Técnicas de Cultivo de Embriones , Partenogénesis , Porcinos , Proteína Destructora del Antagonista Homólogo bcl-2/biosíntesis , Proteína bcl-X/biosíntesisRESUMEN
FZR1 (fizzy-related protein homolog; also known as CDH1 [cell division cycle 20 related 1]) functions in the cell cycle as a specific activator of anaphase-promoting complex or cyclosome ubiquitin ligase, regulating late mitosis, G1 phase, and activation of the G2-M checkpoint. FZR1 has been implicated as both a tumor suppressor and oncoprotein, and its precise contribution to carcinogenesis remains unclear. Here, we examined the role of FZR1 in tumorigenesis and cancer therapy by analyzing tumor models and patient specimens. In an Fzr1 gene-trap mouse model of B-cell acute lymphoblastic leukemia (B-ALL), mice with Fzr1-deficient B-ALL survived longer than those with Fzr1-intact disease, and sensitivity of Fzr1-deficient B-ALL cells to DNA damage appeared increased. Consistently, conditional knockdown of FZR1 sensitized human B-ALL cell lines to DNA damage-induced cell death. Moreover, multivariate analyses of reverse-phase protein array of B-ALL specimens from newly diagnosed B-ALL patients determined that a low FZR1 protein expression level was an independent predictor of a longer remission duration. The clinical benefit of a low FZR1 expression level at diagnosis was no longer apparent in patients with relapsed B-ALL. Consistent with this result, secondary and tertiary mouse recipients of Fzr1-deficient B-ALL cells developed more progressive and radiation-resistant disease than those receiving Fzr1-intact B-ALL cells, indicating that prolonged inactivation of Fzr1 promotes the development of resistant clones. Our results suggest that reduction of FZR1 increases therapeutic sensitivity of B-ALL and that transient rather than tonic inhibition of FZR1 may be a therapeutic strategy.
Asunto(s)
Proteínas Cdh1 , Daño del ADN , Regulación Leucémica de la Expresión Génica , Proteínas de Neoplasias , Leucemia-Linfoma Linfoblástico de Células Precursoras B/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras B/metabolismo , Animales , Proteínas Cdh1/biosíntesis , Proteínas Cdh1/genética , Muerte Celular , Humanos , Ratones , Proteínas de Neoplasias/biosíntesis , Proteínas de Neoplasias/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras B/terapiaRESUMEN
We previously reported that aberrant TGF-ß/Smad2/3 signaling in endometrial cancer (ECA) leads to continuous ubiquitylation of p27(kip1)(p27) by the E3 ligase SCF-Skp2/Cks1 causing its degradation, as a putative mechanism involved in the pathogenesis of this cancer. In contrast, normal intact TGF-ß signaling prevents degradation of nuclear p27 by SCF-Skp2/Cks1 thereby accumulating p27 to block Cdk2 for growth arrest. Here we show that in ECA cell lines and normal primary endometrial epithelial cells, TGF-ß increases Cdh1 and its binding to APC/C to form the E3 ligase complex that ubiquitylates Cks1 and Skp2 prompting their proteasomal degradation and thus, leaving p27 intact. Knocking-down Cdh1 in ECA cell lines increased Skp2/Cks1 E3 ligase activity, completely diminished nuclear and cytoplasmic p27, and obviated TGF-ß-mediated inhibition of proliferation. Protein synthesis was not required for TGF-ß-induced increase in nuclear p27 and decrease in Cks1 and Skp2. Moreover, half-lives of Cks1 and Skp2 were extended in the Cdh1-depleted cells. These results suggest that the levels of p27, Skp2 and Cks1 are strongly or solely regulated by proteasomal degradation. Finally, an inverse relationship of low p27 and high Cks1 in the nucleus was shown in patients in normal proliferative endometrium and grade I-III ECAs whereas differentiated secretory endometrium showed the reverse. These studies implicate Cdh1 as the master regulator of TGF-ß-induced preservation of p27 tumor suppressor activity. Thus, Cdh1 is a potential therapeutic target for ECA and other human cancers showing an inverse relationship between Cks1/Skp2 and p27 and/or dysregulated TGF-ß signaling.
Asunto(s)
Ciclosoma-Complejo Promotor de la Anafase/metabolismo , Quinasas CDC2-CDC28/metabolismo , Inhibidor p27 de las Quinasas Dependientes de la Ciclina/metabolismo , Neoplasias Endometriales/enzimología , Proteínas Quinasas Asociadas a Fase-S/metabolismo , Factor de Crecimiento Transformador beta/fisiología , Proteínas Cdh1/biosíntesis , Proteínas Cdh1/genética , Proteínas Cdh1/metabolismo , Puntos de Control del Ciclo Celular , Línea Celular Tumoral , Núcleo Celular/enzimología , Núcleo Celular/genética , Proliferación Celular , Neoplasias Endometriales/metabolismo , Endometrio/enzimología , Endometrio/crecimiento & desarrollo , Endometrio/metabolismo , Células Epiteliales/enzimología , Células Epiteliales/metabolismo , Femenino , Humanos , Complejo de la Endopetidasa Proteasomal/metabolismoRESUMEN
Although casein kinase 1δ (CK1δ) is at the center of multiple signaling pathways, its role in the expansion of CNS progenitor cells is unknown. Using mouse cerebellar granule cell progenitors (GCPs) as a model for brain neurogenesis, we demonstrate that the loss of CK1δ or treatment of GCPs with a highly selective small molecule inhibits GCP expansion. In contrast, CK1δ overexpression increases GCP proliferation. Thus, CK1δ appears to regulate GCP neurogenesis. CK1δ is targeted for proteolysis via the anaphase-promoting complex/cyclosome (APC/C(Cdh1)) ubiquitin ligase, and conditional deletion of the APC/C(Cdh1) activator Cdh1 in cerebellar GCPs results in higher levels of CK1δ. APC/C(Cdh1) also downregulates CK1δ during cell-cycle exit. Therefore, we conclude that APC/C(Cdh1) controls CK1δ levels to balance proliferation and cell-cycle exit in the developing CNS. Similar studies in medulloblastoma cells showed that CK1δ holds promise as a therapeutic target.
Asunto(s)
Ciclosoma-Complejo Promotor de la Anafase/biosíntesis , Quinasa Idelta de la Caseína/biosíntesis , Proteínas Cdh1/biosíntesis , Sistema Nervioso Central/crecimiento & desarrollo , Neurogénesis/genética , Ciclosoma-Complejo Promotor de la Anafase/genética , Animales , Quinasa Idelta de la Caseína/genética , Proteínas Cdh1/genética , Ciclo Celular/genética , Proliferación Celular/genética , Sistema Nervioso Central/metabolismo , Cerebelo/crecimiento & desarrollo , Cerebelo/metabolismo , Regulación del Desarrollo de la Expresión Génica , Células HeLa , Humanos , Ratones , Neuronas/metabolismo , Interferencia de ARN , Transducción de SeñalRESUMEN
Vitrification apart from all drawbacks on oocyte ultra-structure can affect the oocyte mRNA content. Among those evaluated transcripts, no data is available regarding the effect of vitrification on signal transducer and activator of transcription (STAT3) expression in oocytes and the resulting preimplantation embryos. Considering the bidirectional relationship between E-cadherin (CDH1) and STAT3 and the adverse effect of cryopreservation on adherent junctions, we aimed to ascertain to what extent STAT3 and CDH1 genes expression is affected by vitrification in oocytes and the resulting embryos. The ovine vitrified-warmed and fresh GV oocytes were separately subjected to in vitro maturation and fertilization and cultured up to the blastocyst stage. The relative abundance of STAT3 and CDH1 transcripts were analysed by RT-PCR in both classes of fresh and vitrified GV and MII oocytes and the resulting embryos at 2-7 cells, 8-16 cells, morula, and blastocyst stages. Vitrified oocytes showed lower cleavage (37.8% vs. 95.9%, P<0.001) and blastocyst (8.1% vs. 52.7%, P<0.001) rates compared to control. The relative mRNA abundance of both genes was increased after oocyte maturation indicating their expression was started earlier than expected time proposed for embryonic genomic activation. In embryos derived from both fresh and vitrified oocytes, the maximum concentrations of STAT3 and CDH1 transcripts were observed at 2-7 cells and morula stages, respectively. Moreover, in contrast to CDH1 the relative expression of STAT3 in vitrified derived embryos was higher than embryos derived from fresh oocytes. The overexpression of STAT3 in embryos derived from vitrified oocytes might be the reason for the lower CDH1 expression and in turn the lower developmental competence of the resulting embryos.
Asunto(s)
Blastocisto/metabolismo , Proteínas Cdh1/biosíntesis , Criopreservación/métodos , Desarrollo Embrionario/fisiología , Factor de Transcripción STAT3/biosíntesis , Animales , Cadherinas/biosíntesis , Proteínas Cdh1/genética , Supervivencia Celular , Criopreservación/veterinaria , Femenino , Fertilización In Vitro/métodos , Fertilización In Vitro/veterinaria , Mórula/fisiología , Oocitos/citología , Oogénesis/fisiología , ARN Mensajero/genética , Factor de Transcripción STAT3/genética , Ovinos , Transducción de Señal , VitrificaciónRESUMEN
Whether epithelial-mesenchymal transition (EMT) is always linked to increased tumorigenicity is controversial. Through microRNA (miRNA) expression profiling of mammary epithelial cells overexpressing Twist, Snail or ZEB1, we identified miR-100 as a novel EMT inducer. Surprisingly, miR-100 inhibits the tumorigenicity, motility and invasiveness of mammary tumor cells, and is commonly downregulated in human breast cancer due to hypermethylation of its host gene MIR100HG. The EMT-inducing and tumor-suppressing effects of miR-100 are mediated by distinct targets. While miR-100 downregulates E-cadherin by targeting SMARCA5, a regulator of CDH1 promoter methylation, this miRNA suppresses tumorigenesis, cell movement and invasion in vitro and in vivo through direct targeting of HOXA1, a gene that is both oncogenic and pro-invasive, leading to repression of multiple HOXA1 downstream targets involved in oncogenesis and invasiveness. These findings provide a proof-of-principle that EMT and tumorigenicity are not always associated and that certain EMT inducers can inhibit tumorigenesis, migration and invasion.
Asunto(s)
Carcinogénesis/genética , Movimiento Celular/genética , Transición Epitelial-Mesenquimal/genética , MicroARNs/genética , Invasividad Neoplásica/genética , Animales , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Cadherinas/biosíntesis , Cadherinas/genética , Proteínas Cdh1/biosíntesis , Línea Celular Tumoral , Células Epiteliales/metabolismo , Femenino , Perfilación de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Proteínas de Homeodominio/biosíntesis , Humanos , Ratones , Factores de Transcripción/biosíntesisRESUMEN
In both epididymis and prostate the dynamic cross-talk between the cells is hormonally regulated and, in part, through direct cell-to-cell interactions. Functionality of the male reproductive organs may be affected by exposure to specific chemicals, so-called 'reprotoxicants'. In this study we tested whether early postnatal and prepubertal exposure to anti-androgen flutamide altered the expression of adherens junction genes encoding E-cadherin (CDH1) and ß-catenin (CTNNB1) in adult pig epididymis and prostate. In addition, the expression of mRNAs and proteins for 5α-reductase (ST5AR2) and aromatase (CYP19A1) were examined to show whether flutamide alters metabolism of testosterone. Thus, flutamide was injected into male piglets between Days 2 and 10 and between Days 90 and 98 postnatally (PD2 and PD90; 50 mg/kg bw), tissues that were obtained on postnatal Day 270. To assess the expression of the genes and proteins, real-time RT-PCR and Western blot were performed respectively. Moreover, adherens junction proteins were localized by immunohistochemistry. In response to flutamide, CDH1 and CTNNB1 expressions were down-regulated along the epididymis, mostly in PD2 group (p < 0.001, p < 0.01). In the prostate, CDH1 mRNA and protein expressions were significantly down-regulated (p < 0.01), whereas CTNNB1 mRNA was slightly up-regulated in both flutamide-treated groups. CTNNB1 protein level was markedly elevated in both PD2 (p < 0.001) and PD90 (p < 0.01) groups. In the epididymis, the expression of ST5AR2 and CYP19A1 was down- and up-regulated, respectively (p < 0.05), whereas in the prostate evident decrease in CYP19A1 expression (p < 0.001, p < 0.01, p < 0.05) was demonstrated. In both tissues, membranous immunolocalization of CTNNB1 suggests its involvement in cell-cell adhesion. Overall, flutamide administration resulted in suppression of androgen action in the epididymis and prostate leading to deregulation of CDH1 and CTNNB1 gene expressions which is probably caused by the alterations in the expression of ST5AR2 and CYP19A1 in both reproductive organs.
Asunto(s)
Antagonistas de Andrógenos/farmacología , Proteínas Cdh1/biosíntesis , Flutamida/farmacología , Próstata/metabolismo , beta Catenina/biosíntesis , 3-Oxo-5-alfa-Esteroide 4-Deshidrogenasa/biosíntesis , 3-Oxo-5-alfa-Esteroide 4-Deshidrogenasa/genética , Uniones Adherentes/metabolismo , Andrógenos/metabolismo , Animales , Aromatasa/biosíntesis , Aromatasa/genética , Proteínas Cdh1/genética , Adhesión Celular , Comunicación Celular/efectos de los fármacos , Epidídimo/citología , Epidídimo/metabolismo , Masculino , Próstata/citología , ARN Mensajero/biosíntesis , Porcinos , Testosterona/metabolismo , beta Catenina/genéticaRESUMEN
The endocycle is a common developmental cell cycle variation wherein cells become polyploid through repeated genome duplication without mitosis. We previously showed that Drosophila endocycling cells repress the apoptotic cell death response to genotoxic stress. Here, we investigate whether it is differentiation or endocycle remodeling that promotes apoptotic repression. We find that when nurse and follicle cells switch into endocycles during oogenesis they repress the apoptotic response to DNA damage caused by ionizing radiation, and that this repression has been conserved in the genus Drosophila over 40 million years of evolution. Follicle cells defective for Notch signaling failed to switch into endocycles or differentiate and remained apoptotic competent. However, genetic ablation of mitosis by knockdown of Cyclin A or overexpression of fzr/Cdh1 induced follicle cell endocycles and repressed apoptosis independently of Notch signaling and differentiation. Cells recovering from these induced endocycles regained apoptotic competence, showing that repression is reversible. Recovery from fzr/Cdh1 overexpression also resulted in an error-prone mitosis with amplified centrosomes and high levels of chromosome loss and fragmentation. Our results reveal an unanticipated link between endocycles and the repression of apoptosis, with broader implications for how endocycles may contribute to genome instability and oncogenesis.